Loading...
Clover Health Investments, Corp.
CLOV•NASDAQ
Healthcare
Medical - Healthcare Plans
$3.04
$-0.04(-1.14%)
Clover Health Investments, Corp. (CLOV) Financial Performance & Income Statement Overview
Review Clover Health Investments, Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.77%
↑ 8.77%
Operating Income Growth
77.72%
↑ 77.72%
Net Income Growth
79.84%
↑ 79.84%
Operating Cash Flow Growth
130.07%
↑ 130.07%
Operating Margin
-1.64%
↓ 1.64%
Gross Margin
26.37%
↑ 26.37%
Net Profit Margin
-1.69%
↓ 1.69%
ROE
-7.47%
↓ 7.47%
ROIC
-6.61%
↓ 6.61%
Clover Health Investments, Corp. (CLOV) Income Statement & Financial Overview
Review Clover Health Investments, Corp.'s (CLOV) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $336.96M | $330.99M | $356.26M | $346.92M |
| Cost of Revenue | $243.04M | $249.77M | $248.35M | $265.16M |
| Gross Profit | $93.92M | $81.21M | $107.91M | $81.76M |
| Gross Profit Ratio | $0.28 | $0.25 | $0.30 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $115.02M | $90.20M | $99.92M | $103.79M |
| Operating Expenses | $115.37M | $90.00M | $100.73M | $104.46M |
| Total Costs & Expenses | $358.41M | $339.77M | $349.07M | $369.63M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $344000.00 | $339000.00 | $330000.00 | $318000.00 |
| EBITDA | -$21.14M | -$8.45M | $7.50M | -$22.03M |
| EBITDA Ratio | -$0.06 | -$0.03 | $0.02 | -$0.06 |
| Operating Income | -$21.45M | -$8.79M | $7.19M | -$22.70M |
| Operating Income Ratio | -$0.06 | -$0.03 | $0.02 | -$0.07 |
| Other Income/Expenses (Net) | -$33000.00 | $0.00 | -$17000.00 | -$467000.00 |
| Income Before Tax | -$21.48M | -$8.79M | $7.17M | -$23.17M |
| Income Before Tax Ratio | -$0.06 | -$0.03 | $0.02 | -$0.07 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$22.09M | -$9.15M | $7.41M | -$19.17M |
| Net Income Ratio | -$0.07 | -$0.03 | $0.02 | -$0.06 |
| EPS | -$0.04 | -$0.02 | $0.01 | -$0.04 |
| Diluted EPS | -$0.04 | -$0.02 | $0.01 | -$0.04 |
| Weighted Avg Shares Outstanding | $491.87M | $490.18M | $487.48M | $486.37M |
| Weighted Avg Shares Outstanding (Diluted) | $491.87M | $490.18M | $495.18M | $567.45M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan